HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Radiobiologists

Radiobiologists are key specialists who study how ionizing radiation interacts with biological systems, particularly how it affects cellular function and survival. Their work provides the scientific foundation for radiation-based treatments by investigating how radiation damages DNA, disrupts cellular processes, and influences tissue responses. By examining these effects at the molecular, cellular, and systemic levels, Radiobiologists help optimize the use of radiation in clinical settings, aiming to destroy harmful cells while preserving healthy tissue. They also explore how biological variables—such as oxygen concentration, cell type, and genetic traits—influence an organism’s sensitivity to radiation. These insights support personalized treatment approaches that improve therapeutic precision and safety.

Radiobiologists often work alongside radiation oncologists, dosimetrists, and medical physicists to refine treatment protocols and enhance the effectiveness of combined therapies, such as radiation paired with drugs or immunotherapies. Their expertise is also crucial in setting radiation exposure limits and safety standards in healthcare, industry, and environmental monitoring. As treatments evolve, Radiobiologists remain at the forefront, driving innovation in radioprotective agents, predictive biomarkers, and advanced delivery methods. Their contributions are vital to improving outcomes, reducing treatment-related risks, and ensuring that radiation is used in the most effective and responsible way possible. Their knowledge bridges laboratory science and clinical application, enabling therapies that are both scientifically sound and human-centered.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp